fromIPWatchdog.com | Patents & Intellectual Property Law
5 months agoSplit Third Circuit Upholds Medicare Price Negotiation Program Under Biden IRA
The U.S. Court of Appeals for the Third Circuit in a split decision today affirmed a district court ruling granting summary judgment to the U.S. government that the imposition of a Medicare Drug Price Negotiation Program via the Inflation Reduction Act (IRA) does not violate Bristol Myers Squibb (BMS) and Janssen Pharmaceuticals' constitutional rights. Judge Thomas Hardiman dissented. The underlying case was brought by BMS and Janssen in the U.S. District Court for the District of New Jersey.